Prevalence of multiple sclerosis in British Columbia

Estimating the prevalence of neurological disorders remains a challenge in public health. Existing data often lack precision due to diagnostic variability and incomplete case identification. Prior research has shown that MS prevalence varies widely across regions, but few studies have captured comprehensive patient records. This gap motivated a province-wide effort to improve diagnostic accuracy. British Columbia had limited data on MS prevalence before this work. Neurologists' records were considered a key source for identifying cases. Other sources like clinics and specialists were also explored. This study aimed to refine prevalence estimates using multiple diagnostic sources.

The study aimed to determine the prevalence of multiple sclerosis in British Columbia. It focused on improving diagnostic accuracy through a multi-source approach. Researchers wanted to capture a complete picture of MS cases in the province. They selected July 1, 1982, as the prevalence date. Neurologists' records were prioritized for their diagnostic reliability. Additional sources like clinics and patient referrals were included. The goal was to minimize underreporting by combining multiple data streams. This approach allowed for a more comprehensive prevalence estimate.

Researchers reviewed neurologists' files in British Columbia as the primary data source. A single researcher examined 239,412 files using modified Schumacher criteria. Other sources included MS clinics, general practitioners, and specialists. Patient self-referrals and long-term care facilities were also considered. Cases were classified as definite, probable, or possible MS. Optic neuritis was included as a potential indicator. A total of 4,620 unique cases were identified. These cases were categorized using standardized diagnostic criteria.

The study identified 4,620 non-duplicated MS cases in British Columbia. Of these, 4,112 were classified using neurologists' records. The prevalence of definite/probable MS was 93.3 per 100,000 people. Including possible MS and optic neuritis raised the rate to 130.5 per 100,000. These figures are among the highest reported in Canada or globally. Neurologists' records provided the most accurate classifications. Additional sources contributed to identifying remaining cases. The high prevalence suggests a need for further regional analysis.

The study found high MS prevalence in British Columbia compared to global averages. Neurologists' records were critical for accurate diagnosis. Combining multiple data sources improved case identification. The prevalence of 93.3 per 100,000 is among the highest reported. Including possible cases increased the rate to 130.5 per 100,000. These findings suggest regional factors may influence MS rates. The study's comprehensive approach enhances diagnostic reliability. Future work should explore why B.C. has higher prevalence rates.